Bill

Bill > H2325


MA H2325

Relative to pharmacy testing


summary

Introduced
03/29/2021
In Committee
03/29/2021
Crossed Over
Passed
Dead
12/31/2022

Introduced Session

192nd General Court

Bill Summary

For legislation to establish a written statewide protocol for pharmacists to test or screen for and initiate treatment or therapy for qualified health conditions. Public Health.

AI Summary

This bill establishes a written statewide protocol for pharmacists to test or screen for and initiate treatment or therapy for qualified health conditions, including influenza, streptococcal infections, COVID-19, HIV, and any other conditions approved by the Board of Pharmacy. Pharmacists can collect or oversee the collection of specimens and send them to authorized laboratories for testing. If the test can be processed at a CLIA-waived facility or pharmacy, it may be done there. Pharmacists must advise patients who test positive for COVID-19 to follow Department of Public Health guidelines, and for high-risk patients or those experiencing severe symptoms, to seek further treatment. The bill also requires insurance carriers and pharmacy benefit managers to develop provider and consult codes to compensate pharmacists for these services.

Committee Categories

Health and Social Services

Sponsors (7)

Last Action

Accompanied a study order, see H5035 (on 09/06/2022)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...